CADI-R102

CADI-R102 is a discovery-stage research program developed by Bio-Modeling Systems (BMSystems) focused on the fields of infection and immunology. The program utilizes the company's proprietary CADI™ (Computer Assisted Deductive Integration) platform, which employs a heuristic systems biology approach to generate predictive models of complex biological pathways. By integrating diverse datasets, CADI-R102 aims to identify novel therapeutic targets or treatment protocols for infectious diseases and immune system dysfunctions. As of the current reporting, the program remains in the early discovery phase with specific molecular targets and modalities not yet publicly disclosed.